Regulatory

Regulatory  ·  Weekly Digest 4
Gossamer Bio discontinued its BTK inhibitor developement in CNS Lymphoma

Weekly Digest – 01-07 Apr 2023 Weekly Digest – 01-07 Apr 2023 04 Apr 2023: GB5121 / Primary CNS lymphoma / Gossamer Bio: Developement discontinued following two patient deaths Following two patient deaths in the Phase 1b/2 STAR-CNS study, the […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 4
FDA approved Keytruda and Padcev (enfortumab vedotin-ejfv) combination for the trearment of Urothelial cancer

Weekly Digest – 01-07 Apr 2023 Weekly Digest – 01-07 Apr 2023 04 Apr 2023: Keytruda / Padcev (enfortumab vedotin-ejfv) / 1L Urothelial cancer / Merck / Astellas Pharma / Seagen: US FDA granted accelerated approval for KEYNOTE-869 trial FDA […]

by Sandhya Ramalingam

Continue Reading